Skip to Content

Berger & Montague Press Releases

Berger & Montague Press Releases

If you are a member of the news media, an established news blogger, or a news or feature producer seeking to develop a story concerning a legal subject or newsworthy case, please visit our For The Media page.

Proposed Settlement Reached in Bally Total Fitness Securities Fraud Class Action;

PHILADELPHIA, Sept. 21 /PRNewswire/ -- Counsel for Plaintiffs in the In re: Bally Total Fitness Securities Litigation class action have announced the following: UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION In re...

Case Accusing Chase, Others of Conspiring on Arbitration Clauses is Partially Settled

PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- Berger & Montague, P.C. announces a tentativesettlement with JPMorgan Chase and related companies that partially resolves a four-year-old lawsuit accusing Chase and other credit card companies of...

Plaintiffs File Class Action Against Monaco Coach Corporation Alleging Violations of the Worker Adjustment and Retaining Notification Act

PHILADELPHIA, March 16 /PRNewswire-USNewswire/ -- Berger & Montague, P.C. has filed a class action lawsuit in the United States Bankruptcy Court for the District of Delaware, Rieke, et al. v. Monaco Coach Corporation, Civil Action No. 09-50444-KJC,...

Judge Rules Whistleblower Lawsuit against Abbott Laboratories Inc. Filed by Berger & Montague on behalf of Its Client, the U.S. and Numerous States, May Proceed

On July 16, 2010, the Honorable Richard Stearns ruled that Plaintiff Carpenter's allegations of violations of the federal False Claims Act, 32 U.S.C. Section 3729(a)(1) arising from Abbott's alleged promotion of its AIDS drug Kaletra, for uses unapproved by the F.D.A., could proceed. Specifically, Plaintiff alleges that contrary to the F.D.A. approved uses and dosing for the drug, Abbott 1) promoted once daily dosing for therapy-experienced AIDS patients although such dosing was only approved for AIDS patients new to drug therapy and 2) promoted Kaletra as a single treatment regimen (monotherapy) rather than for use in combination with other anti-AIDS drugs. Simultaneously, the Court dismissed Plaintiff Carpenter's false claims allegations arising from alleged violations of the federal anti-kickback statute and Section (a)(2) of the False Claims Act. Discovery will now proceed in the case.

Pet Food

If You Purchased or Your Pet(s) Consumed Recalled Pet Food, You May Be Eligible To Participate in a Class Action Settlement

Berger & Montague named to NLJ Plaintiffs' Hot List Hall of Fame

In 2010, Berger & Montague was named to the National Law Journal's "Plaintiff's Hot List" for the 7th time in 8 years. The NLJ designated the firm to it's Hall of Fame for having been recognized on the list in 2003-2005 and 2007-2010.

Court Grants Final Approval of Settlements Reached with Four Credit Card Companies to Drop Mandatory Arbitration Clauses

Berger & Montague, P.C., as lead counsel for the cardholder classes in Ross, et al. v. Bank of America, N.A., et al., No. 05-cv-7116 (S.D.N.Y., Pauley, J.), has obtained final approval of the first settlements nation-wide removing arbitration...

Judge Rules that Whistleblower Lawsuit against Wyeth/Pfizer Filed by Berger & Montague on Behalf of Its Client May Proceed

On February 24, 2010, Judge Douglas P. Woodlock of the U.S. District Court in Boston denied the motion to dismiss filed by Wyeth (now known as Pfizer). The case against Wyeth will now proceed to discovery. Plaintiffs allege that Wyeth knowingly failed...

19 Additional States Have Now Chosen to Join in the Prosecution of Whisteblower Lawsuit against Wyeth

On July 15, the U.S. District Court in Massachusetts granted motions allowing 19 additional states to join in the prosecution of this whistleblower lawsuit against pharmaceutical company Wyeth, Inc. (now known as Pfizer) that was filed by Berger &...

Settlement Reached with Four Credit Card Companies to Drop Mandatory Arbitration Clauses

Berger & Montague, P.C., on behalf of cardholder classes, has reached tentative settlements with four credit card companies in a four-year-old lawsuit accusing six major credit card banks, and one arbitration provider, of unlawfully colluding to require cardholders to arbitrate disputes, including debt collections, and to preclude cardholders from participating in any class actions. The settling card companies are Chase, Bank of America, Capital One and HSBC. All settlements are subject to court approval. The lawsuit remains pending against Citibank, Discover and the National Arbitration Forum in the United States District Court for the Southern District of New York, as Ross, et al. v. Bank of America, N.A., et al., No. 05-cv-7116 and is a part of In re Currency Conversation Fee Antitrust Litigation, MDL No. 1409, in the same court.
Go to page: 1 2 3 4